UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 165

Sortiert nach

CA-047: Efficacité et sécurité de la dapagliflozine chez les patients diabétiques de type 2 insuffisants cardiaques

Diabetes & metabolism, 2016-03, Vol.42, p.A48-A48

2016

Link zum Volltext

Verfügbarkeit prüfen

CA-039: Pas de majoration du risque d'événements cardiovasculaires avec la dapagliflozine chez les patients âgés atteints de diabète de type 2, de maladie cardiovasculaire et d'hypertension

Diabetes & metabolism, 2016-03, Vol.42, p.A45-A45

2016

Link zum Volltext

Verfügbarkeit prüfen

A recycling framework for the construction of Bonferroni-based multiple tests

Statistics in medicine, 2009-02, Vol.28 (5), p.739-761

2009

Link zum Volltext

Verfügbarkeit prüfen

Results after sacral nerve stimulation for chronic constipation

Neurogastroenterology and motility, 2015-05, Vol.27 (5), p.734-739

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

Movement disorders, 2020-06, Vol.35 (6), p.1046-1054

2020

Link zum Volltext

Verfügbarkeit prüfen

Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease

Journal of Huntington's disease, 2018-01, Vol.7 (1), p.1

2018

Link zum Volltext

Verfügbarkeit prüfen

A review and discussion of prospective statistical surveillance in public health

Journal of the Royal Statistical Society. Series A, Statistics in society, 2003-01, Vol.166 (1), p.5-21

2003

Link zum Volltext

Verfügbarkeit prüfen

The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition

Progress in neuro-psychopharmacology & biological psychiatry, 2004-07, Vol.28 (4), p.677-685

2004

Link zum Volltext

Verfügbarkeit prüfen

Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease

Neurology, 1999-10, Vol.53 (7), p.1605

1999

Link zum Volltext

Verfügbarkeit prüfen

P.l.c.043 ACR325: a dopaminergic stabiliser that displays state-dependent effects in-vivo

European neuropsychopharmacology, 2009, Vol.19, p.S276-S276

2009

Link zum Volltext

Verfügbarkeit prüfen

A first‐in‐human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers

Pharmacology research & perspectives, 2021-05, Vol.9 (3), p.e00792-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

First‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers

Clinical pharmacology in drug development, 2021-12, Vol.10 (12), p.1485-1494

2021

Link zum Volltext

Verfügbarkeit prüfen

The dopaminergic stabilizer pridopidine decreases expression of l-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model

European journal of pharmacology, 2013-01, Vol.698 (1-3), p.278-285

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial

NPJ Parkinson's Disease, 2018, Vol.4 (1), p.35-5, Article 35

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery

ACS chemical neuroscience, 2017-04, Vol.8 (4), p.785-797

2017

Link zum Volltext

Verfügbarkeit prüfen

What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden

Pharmacoepidemiology and drug safety, 2005-05, Vol.14 (5), p.341-348

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease

Clinical neuropharmacology, 2010-09, Vol.33 (5), p.260-264

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluations of some Exponentially Weighted Moving Average methods

Journal of applied statistics, 2003-12, Vol.30 (10), p.1115-1133

Sonesson, Christian

2003

Link zum Volltext

Verfügbarkeit prüfen

Q06Multivariate classification of central nervous system-acting drugs based on in vivo response patterns - profile of pridopidine

Journal of neurology, neurosurgery and psychiatry, 2012-09, Vol.83 (Suppl 1), p.A56-ft-A56

2012

Link zum Volltext

Verfügbarkeit prüfen

Q06 Multivariate classification of central nervous system-acting drugs based on in vivo response patterns – profile of pridopidine

Journal of neurology, neurosurgery and psychiatry, 2012-09, Vol.83 (Suppl 1), p.A56-A56

2012

Link zum Volltext

Verfügbarkeit prüfen

DA stabilisers — fourth generation antipsychotic drugs

SCHIZOPHRENIA RESEARCH, 2003, Vol.60 (1), p.119-119

2003

Link zum Volltext

Verfügbarkeit prüfen

2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists

Bioorganic & medicinal chemistry letters, 2005-10, Vol.15 (19), p.4230-4234

2005

Link zum Volltext

Verfügbarkeit prüfen

Relative growth estimated from self-administered symphysis fundal measurements

Acta obstetricia et gynecologica Scandinavica, 2011-02, Vol.90 (2), p.179-185

2011

Link zum Volltext

Verfügbarkeit prüfen

Self-administered symphysis-fundus measurements analyzed with a novel statistical method for detection of intrauterine growth restriction: a clinical evaluation

Acta obstetricia et gynecologica Scandinavica, 2011-08, Vol.90 (8), p.890-896

2011

Link zum Volltext

Verfügbarkeit prüfen

Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour

Journal of Neural Transmission, 1994-01, Vol.98 (1), p.39-55

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CA-047: Efficacité et sécurité de la dapagliflozine chez les patients diabétiques de type 2 insuffisants cardiaques

CA-039: Pas de majoration du risque d'événements cardiovasculaires avec la dapagliflozine chez les patients âgés atteints de diabète de type 2, de maladie cardiovasculaire et d'hypertension

A recycling framework for the construction of Bonferroni-based multiple tests

Results after sacral nerve stimulation for chronic constipation

A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia

Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease

A review and discussion of prospective statistical surveillance in public health

The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition

Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease

P.l.c.043 ACR325: a dopaminergic stabiliser that displays state-dependent effects in-vivo

A first‐in‐human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers

First‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers

The dopaminergic stabilizer pridopidine decreases expression of l-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model

Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial

In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery

What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden

Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease

Evaluations of some Exponentially Weighted Moving Average methods

Q06Multivariate classification of central nervous system-acting drugs based on in vivo response patterns - profile of pridopidine

Q06 Multivariate classification of central nervous system-acting drugs based on in vivo response patterns – profile of pridopidine

DA stabilisers — fourth generation antipsychotic drugs

2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists

Relative growth estimated from self-administered symphysis fundal measurements

Self-administered symphysis-fundus measurements analyzed with a novel statistical method for detection of intrauterine growth restriction: a clinical evaluation

Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour

Suchergebnisse filtern